47 related articles for article (PubMed ID: 18476948)
1. Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden.
Dobilas A; Jansåker F; Li X; Sundquist K; Borgfeldt C
BMC Cancer; 2023 Oct; 23(1):951. PubMed ID: 37807065
[TBL] [Abstract][Full Text] [Related]
2. Is There Re-staging Surgery Necessity for Borderline Ovarian Tumors.
Guo LL; Kang XY; Su Y; Liu XY; Wu X; Xie W; Liu YH; Wang CY
Curr Med Sci; 2023 Aug; 43(4):822-830. PubMed ID: 37455277
[TBL] [Abstract][Full Text] [Related]
3. Borderline ovarian tumor in pregnancy: can surgery wait? A case series.
Vidal Urbinati AM; Iacobone AD; Di Pace RC; Pino I; Pittelli MR; Guerrieri ME; Preti EP; Franchi D
Arch Gynecol Obstet; 2021 Dec; 304(6):1561-1568. PubMed ID: 33950305
[TBL] [Abstract][Full Text] [Related]
4. What is your diagnosis?
Mangla M; Sivakoti S; Gabbeta S; Kumar N; Shrinivas SB; Srirambhatla A
J Turk Ger Gynecol Assoc; 2023 Sep; 24(3):220-224. PubMed ID: 37675558
[No Abstract] [Full Text] [Related]
5. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
Wang P; Fang L
World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
[TBL] [Abstract][Full Text] [Related]
6. Borderline ovarian tumours: management in the era of fertility-sparing surgery.
Maramai M; Barra F; Menada MV; Stigliani S; Moioli M; Costantini S; Ferrero S
Ecancermedicalscience; 2020; 14():1031. PubMed ID: 32419843
[TBL] [Abstract][Full Text] [Related]
7. Impact of age on clinicopathological features and survival of epithelial ovarian neoplasms in reproductive age.
Hanatani M; Yoshikawa N; Yoshida K; Tamauchi S; Ikeda Y; Nishino K; Niimi K; Suzuki S; Kawai M; Kajiyama H; Kikkawa F
Int J Clin Oncol; 2020 Jan; 25(1):187-194. PubMed ID: 31541363
[TBL] [Abstract][Full Text] [Related]
8. Borderline tumours of the ovary: Common practice in the Netherlands.
De Decker K; Ter Brugge HG; Bart J; Kruitwagen RFPM; Nijman HW; Kruse AJ
Gynecol Oncol Rep; 2019 Feb; 27():25-30. PubMed ID: 30581952
[TBL] [Abstract][Full Text] [Related]
9. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent difference in impact of fertility preserving surgery on disease-specific survival in women with stage I borderline ovarian tumors.
Sun H; Chen X; Zhu T; Liu N; Yu A; Wang S
J Ovarian Res; 2018 Jun; 11(1):54. PubMed ID: 29958541
[TBL] [Abstract][Full Text] [Related]
11. Identification of factors that impact recurrence in patients with borderline ovarian tumors.
Chen X; Fang C; Zhu T; Zhang P; Yu A; Wang S
J Ovarian Res; 2017 Apr; 10(1):23. PubMed ID: 28376898
[TBL] [Abstract][Full Text] [Related]
12. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.
Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ
Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817
[TBL] [Abstract][Full Text] [Related]
13. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis on the impact of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors with invasive implants.
Vasconcelos I; Olschewski J; Braicu I; Sehouli J
Oncologist; 2015 Feb; 20(2):151-8. PubMed ID: 25601963
[TBL] [Abstract][Full Text] [Related]
15. A nationwide study of serous "borderline" ovarian tumors in Denmark 1978-2002: centralized pathology review and overall survival compared with the general population.
Hannibal CG; Vang R; Junge J; Frederiksen K; Kjaerbye-Thygesen A; Andersen KK; Tabor A; Kurman RJ; Kjaer SK
Gynecol Oncol; 2014 Aug; 134(2):267-73. PubMed ID: 24924123
[TBL] [Abstract][Full Text] [Related]
16. Histologic distribution of borderline ovarian tumors worldwide: a systematic review.
Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
J Gynecol Oncol; 2013 Jan; 24(1):44-51. PubMed ID: 23346313
[TBL] [Abstract][Full Text] [Related]
17. High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer.
Kalapotharakos G; Asciutto C; Henic E; Casslén B; Borgfeldt C
J Ovarian Res; 2012 Aug; 5(1):20. PubMed ID: 22909379
[TBL] [Abstract][Full Text] [Related]
18. Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period.
Akeson M; Zetterqvist BM; Dahllöf K; Jakobsen AM; Brännström M; Horvath G
Int J Gynecol Cancer; 2008; 18(3):453-9. PubMed ID: 18476948
[TBL] [Abstract][Full Text] [Related]
19. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
